Replies to post #36153 on Biotech Values

[DewDiligence]

Thermage addendum: if they get the IPO off the ground, I plan to watch the stock. It could make one of the best short sales since Eyetech, especially as it nears the insider-lockup expiration.

[DewDiligence]

Thermage Cuts IPO Price to $8-$9 from $11-$13

[LOL—even at this lower price range, I’m keeping Thermage on my watch list for eventual shorting because I’m pretty sure the product does not work.]

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20061109:MTFH44418_2...

>>
Thu Nov 9, 2006 7:06 AM ET

WASHINGTON, Nov 9 (Reuters) - Thermage Inc., a wrinkle treatment medical company, on Thursday cut the expected price of its planned initial public offering to $8 to $9 per share from $11 to $13.

The company still intends to sell 6 million shares in the IPO, according to an amended offering document filed with the U.S. Securities and Exchange Commission. Merrill Lynch & Co., Thomas Weisel Partners LLC, Wachovia Securities, C. E. Unterberg Towbin, and Maxim Group LLC are underwriting the IPO.
<<